Subgroup Analysis of Topical Tranexamic Acid in Primary Total Hip Arthroplasty

  • Walter Anazonwu Warren Alpert Medical School of Brown University, Providence, RI, USA
  • John Tuttle Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Lee Rubin Warren Alpert Medical School of Brown University, Providence, RI, USA
DOI: https://doi.org/10.15438/rr.5.1.80

Abstract

Tranexamic acid (TXA) is an antifibrinolytic agent that can effectively be utilized for the reduction of blood loss when administered via intravenous or intraarticular injection following total joint arthroplasty. Despite data published to date, it remains unclear as to which specific patient groups undergoing primary total hip arthroplasty (THA) would benefit most regarding transfusion reduction from TXA administration. Using a retrospective cohort study model involving 123 THA patients who received topical TXA compared against 111 THA controls who did not receive TXA, we assessed data within the following subgroups: age, gender, BMI, preoperative hemoglobin, and surgical approach. Critical analysis of these subgroups revealed that the most reliable and consistent response to TXA was found in patients who were female and over 65 years old. Continued study of TXA administration in THA is essential to help reduce blood losses, minimize blood product transfusion, and improve outcomes following THA.
Published
2015-03-31
How to Cite
Anazonwu, W., Tuttle, J., & Rubin, L. (2015). Subgroup Analysis of Topical Tranexamic Acid in Primary Total Hip Arthroplasty. Reconstructive Review, 5(1). https://doi.org/10.15438/rr.5.1.80
Issue
Vol. 5 No. 1 (2015)
Section
Clinical/Surgical

Copyright (c) 2015 Walter Anazonwu, John Tuttle, Lee Rubin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright and License Agreement: 

Authors who publish with the Reconstructive Review agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work. Reconstructive Review follows the Creative Commons Attribution-NonCommercial CC BY-NC. This license allows anyone to download works, build upon the material, and share them with others for non-commercial purposes as long as they credit the senior author, Reconstructive Review, and the Joint Implant Surgery & Research Foundation (JISRF). An example credit would be: "Courtesy of (senior author's name), Reconstructive Review, JISRF, Chagrin Falls, Ohio". While works can be downloaded and shared they cannot be used commercially.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.